[ad_1]
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) in the present day introduced the launch of a first-to-market generic model of Narcan (naloxone hydrochloride nasal spray), within the US.
Teva stated that aloxone hydrochloride nasal spray is a prescription drugs used for the therapy of opioid emergencies corresponding to an overdose or a doable opioid overdose with indicators of respiratory issues and extreme sleepiness, or not having the ability to reply.
RELATED ARTICLES
With practically 550 generic medicines out there, Teva has the most important portfolio of FDA-approved generic merchandise available on the market, and holds the main place in first-to-file alternatives, with 100 pending first-to-files within the US At present, 1 in 12 generic prescriptions distributed within the US is stuffed with a Teva generic product.
Teva is presently going through authorized proceedings all through the US in instances alleging its involvement within the manufacture and distribution of extremely addictive opioid painkillers.
Printed by Globes, Israel enterprise information – en.globes.co.il – on December 23, 2021.
© Copyright of Globes Writer Itonut (1983) Ltd., 2021.
[ad_2]
Source link